Scar sarcoidosis after hyaluronic acid injection

被引:30
作者
Dal Sacco, D [1 ]
Cozzani, E [1 ]
Parodi, A [1 ]
Rebora, A [1 ]
机构
[1] Univ Genoa, Dermatol Sect, DiSEM, I-16132 Genoa, Italy
关键词
D O I
10.1111/j.1365-4632.2005.01930.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
A 54-year-old woman presented with a 5-month history of tender nodules in both nasolabial folds that had developed 4 months after the injection of hyaluronic acid (HA) (Restylane((R))) for wrinkles. The patient was treated with 1.5 mg /day betamethasone for 6 days and her lesions disappeared within 1 week. About 8 days after stopping therapy, however, new nodules developed at the same site, on previously healthy buttocks, and on old scars. On examination, nodules of about 0.5-1 cm in size were palpable at the nasolabial folds, and red nodules were present on the buttocks (Fig. 1) and on two old scars. Laboratory tests disclosed an increased protein C reaction (7.9 mg/L; normal value, < 5 mg/L) and acetylconverting enzyme test (14.5 U/L; normal value, < 9 U/L). A chest X-ray was normal. Lung function tests showed a decreased lung CO diffusion, and chest axial tomography disclosed fibrosis, increased parenchyma density, and calcifications, findings suggestive of a diagnosis of lung sarcoidosis. An X-ray of the hands showed some bone cysts. Interestingly, two granulomatous lesions were observed at the sites of venipuncture. Histology of a gluteal lesion biopsy showed a deep granuloma with epithelioid and Langhans cells in the absence of necrobiosis. Sarcoidosis was diagnosed and the patient was given 50 mg/day prednisone with clear clinical improvement of cutaneous lesions in about 6 months. Decreased parenchyma density was also observed by chest axial tomography.
引用
收藏
页码:411 / 412
页数:2
相关论文
共 13 条
[1]
CHOFFEL C, 1981, NOUV PRESSE MED, V10, P697
[2]
Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation [J].
Friedman, PM ;
Mafong, EA ;
Kauvar, ANB ;
Geronemus, RG .
DERMATOLOGIC SURGERY, 2002, 28 (06) :491-494
[3]
HEALSMITH MF, 1992, CLIN EXP DERMATOL, V17, P369
[4]
Hyaluronic acid skin fillers: Adverse reactions and skin testing [J].
Lowe, NJ ;
Maxwell, CA ;
Lowe, P ;
Duick, MG ;
Shah, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (06) :930-933
[5]
Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel [J].
Lupton, JR ;
Alster, TS .
DERMATOLOGIC SURGERY, 2000, 26 (02) :135-137
[6]
CUTANEOUS SARCOIDOSIS IN VENIPUNCTURE SITES [J].
MACGREGOR, G .
BMJ-BRITISH MEDICAL JOURNAL, 1973, 1 (3849) :357-357
[7]
Human anti-hyaluronic acid antibodies: Is it possible? [J].
Micheels, P .
DERMATOLOGIC SURGERY, 2001, 27 (02) :185-191
[8]
Loss of purinergic P2X3 and P2X5 receptor innervation in human detrusor from adults with urge incontinence [J].
Moore, KH ;
Ray, FR ;
Barden, JA .
JOURNAL OF NEUROSCIENCE, 2001, 21 (18)
[9]
Raulin C, 2000, CONTACT DERMATITIS, V43, P178
[10]
Systemic reaction to viscosupplementation for knee osteoarthritis [J].
Rees, JD ;
Wojtulewski, JA .
RHEUMATOLOGY, 2001, 40 (12) :1425-U7